“Melatonin gummies are a harmless way to get children to sleep.”
An editorial question about whether melatonin gummies are harmless for children.
In Australia, melatonin is prescription-only for children and approved only in limited circumstances, including insomnia in children and adolescents with autism spectrum disorder and/or Smith-Magenis syndrome. The TGA says safety and efficacy have not been evaluated for broader use in children. It also warns that imported, unregistered products may have inaccurate or undisclosed ingredients. A small US study of 25 gummy products found 22 inaccurately labelled; its results may not generalise to Australian products.
If your child is having trouble sleeping, what concerns or questions would you want to discuss with their doctor before considering melatonin?
Regulation of melatonin products in Australia | Therapeutic Goods Administration (TGA) · Source document
Safety concerns over imported melatonin products · Source document
Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US - PMC · Source document
The source exceeds the research excerpt. Check the full linked document before drawing clinical conclusions.
Evidence checked November 04, 2026 · Reviewed November 04, 2026
Curated topic researched on demand from indexed public sources, not platform-wide monitoring. Attention and prevalence are not measured; the claim itself is editorial. Some searches or retrievals failed; review the research scope before publishing.
What changed
November 04, 2026 In Australia, melatonin is prescription-only for children and approved only in limited circumstances, including insomnia in children and adolescents with autism spectrum disorder and/or Smith-Magenis syndrome. The TGA says safety and efficacy have not been evaluated for broader use in children. It also warns that imported, unregistered products may have inaccurate or undisclosed ingredients. A small US study of 25 gummy products found 22 inaccurately labelled; its results may not generalise to Australian products.
November 03, 2026 The TGA says melatonin is approved for children in Australia only as a prescription medicine for insomnia in 2–18-year-olds with autism spectrum disorder and/or Smith-Magenis syndrome. Safety and effectiveness for broader use in children have not been evaluated. Unregistered products bought online may contain more, less or no melatonin compared with their labels, and can contain undisclosed harmful ingredients. The TGA warns of serious side effects, hospitalisation and accidental overdose, especially in children.
GPT-6 Luna “Harmless” is too reassuring: unregistered gummies can contain unpredictable amounts, and children may face risks including accidental overdose or serious side effects. The evidence supplied does not show that every melatonin product is harmful; it supports caution, medical oversight and distinguishing regulated medicines from unregistered supplements.
DeepSeek V4.1 Flash The claim is not supported. Australian melatonin use in children is prescription-only for limited indications, with broader use not assessed for safety or efficacy. TGA testing found imported gummies with up to 417% of labelled content, and some with no melatonin. A US study found 22 of 25 gummies inaccurately labelled, mostly exceeding declared amounts. Paediatric use carries risks including accidental overdose and hospitalisation, and seizure disorders may worsen. Gummies are not harmless; use should involve a doctor and regulated products.
Grok 4.7 The claim is not supported. In Australia, melatonin is approved for children only as a prescription medicine for insomnia in autism spectrum disorder and/or Smith-Magenis syndrome, ages 2 to 18. Broader paediatric safety and efficacy have not been evaluated. Imported gummies are often unregistered. Testing found doses from none to more than four times the label, with overdose, hospitalisation, and possible increased seizures reported. A small US study also found widespread mislabelling and some CBD. These findings do not assess every regulated prescription product. Use requires clinician oversight, not unsupervised gummies.
